Exact Sciences Appoints New Chief Legal Officer

Ticker: EXAS · Form: 8-K · Filed: 2024-04-15T00:00:00.000Z

Sentiment: neutral

Topics: executive-appointment, legal

Related Tickers: TMO

TL;DR

Exact Sciences just hired a new Chief Legal Officer, Paul J. D. Radin, from Thermo Fisher.

AI Summary

Exact Sciences Corp. announced on April 15, 2024, the appointment of Paul J. D. Radin as its new Chief Legal Officer. Radin previously served as Senior Vice President and General Counsel at Thermo Fisher Scientific. This appointment is part of the company's ongoing efforts to strengthen its leadership team.

Why It Matters

The appointment of a new Chief Legal Officer can signal strategic shifts or a focus on compliance and risk management within the company.

Risk Assessment

Risk Level: low — This filing is an administrative update regarding a personnel change and does not involve significant financial or operational risks.

Key Players & Entities

FAQ

Who has been appointed as the new Chief Legal Officer of Exact Sciences Corp.?

Paul J. D. Radin has been appointed as the new Chief Legal Officer of Exact Sciences Corp.

What was Paul J. D. Radin's previous role?

Paul J. D. Radin previously served as Senior Vice President and General Counsel at Thermo Fisher Scientific.

On what date was this report filed?

This report was filed on April 15, 2024.

What is the principal executive office address for Exact Sciences Corp.?

The principal executive office address is 5505 Endeavor Lane, Madison, WI 53719.

What is the SIC code for Exact Sciences Corp.?

The Standard Industrial Classification (SIC) code for Exact Sciences Corp. is 8071, which corresponds to Medical Laboratories.

From the Filing

0001124140-24-000015.txt : 20240415 0001124140-24-000015.hdr.sgml : 20240415 20240415060242 ACCESSION NUMBER: 0001124140-24-000015 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240415 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240415 DATE AS OF CHANGE: 20240415 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EXACT SCIENCES CORP CENTRAL INDEX KEY: 0001124140 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 204782291 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35092 FILM NUMBER: 24843032 BUSINESS ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 BUSINESS PHONE: 608-284-5700 MAIL ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 FORMER COMPANY: FORMER CONFORMED NAME: EXACT CORP DATE OF NAME CHANGE: 20000919 8-K 1 exas-20240415.htm 8-K exas-20240415 0001124140 false 0001124140 2024-04-15 2024-04-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM  8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported):  April 15, 2024   EXACT SCIENCES CORPORATION (Exact Name of Registrant as Specified in Charter)   Delaware   001-35092   02-0478229 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   5505 Endeavor Lane Madison , WI   53719 (Address of Principal Executive Offices)(Zip Code)   Registrant’s telephone number, including area code:   ( 608 ) 284-5700   Not Applicable (Former Name or Former Address, if Changed Since Last Report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐              Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐             Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value per share EXAS The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 5.02.                      Departure of Directors or Certain Officers; Election of Directors; Appointme

View on Read The Filing